Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Genentech Inc.
DescriptionAntibody drug conjugate (ADC) that consists of a humanized mAb against STEAP1
Molecular Target
Mechanism of ActionAntibody-drug conjugate
Therapeutic ModalityBiologic: Antibody-drug conjugate
Latest Stage of DevelopmentPhase I
Standard IndicationProstate cancer
Indication DetailsTreat prostate cancer
Regulatory Designation
PartnerSeattle Genetics Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today